IRCT20100209003320N17 IRCT 2019-12-22 Tabriz University of Medical Sciences The effect of DASH diet on NAFLD NAFLD The effect of DASH-based weight loss diet on serum Lipopolysaccharide level and meta-inflammation status among patients with non-alcoholic fatty liver disease 2019-10-23 anticipated 44 Complete https://irct.ir/trial/42625 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: 44 eligible patients will be randomly allocated to intervention and placebo groups using a software generated random permuted blocks. The generated random sequence will be kept in a protected location and administered by an independent third party who is blind to the trial throughout the study, Blinding description: In this study, the main investigators (including the student and her supervisors and adviser professors), as well as the patients will be blinded to the type of diet (DASH diet or the usual weight loss diet) received by each group. N/A Non alcoholic fatty liver disease. Intervention 1: Intervention group: Patients in this group will receive the DASH-based weight loss diet for 8 weeks. Intervention 2: Control group: Patients in this group will receive the usual weight loss diet for 8 weeks. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information